Attached Carole Ho - 31 Dec 2025 Form 3 Insider Report for ELI LILLY & Co (LLY)

Role
EVP & Pres, Lilly Neuroscience
Signature
/s/ Jonathan Groff for Carole Ho, pursuant to authorization attached
Issuer symbol
LLY
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
3
Filing time
06 Jan 2026, 16:13:56 UTC
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ho Carole EVP & Pres, Lilly Neuroscience LILLY CORPORATE CENTER, INDIANAPOLIS /s/ Jonathan Groff for Carole Ho, pursuant to authorization attached 06 Jan 2026 0001724605

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LLY Restricted Stock Unit 31 Dec 2025 Common Stock 2,741 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three installments, 904.631 on December 1, 2026, 932.044 on December 1, 2027, and 904.631 on December 1, 2028.
F2 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Remarks:

Exhibit 24 - Power of Attorney